A newly identified “metabolic signature” can evaluate an individual’s adherence and metabolic response to the Mediterranean diet and help predict future risk of developing cardiovascular disease (CVD), according to new research.
The Association for the Cannabinoid Industry (ACI) has received clarification from the Food Standards Agency (FSA) regarding updated deadlines set for Cannabinoid (CBD) firms to apply for Novel Foods status.
US-based Kemin Industries has received a positive safety assessment from the European Food Safety Authority (EFSA) for its algae-sourced beta glucan ingredient, BetaVia. This unlocks the opportunity for ‘innovative product developers to be the first to...
Eating at least two daily servings of high fat dairy, but not low fat, is linked to lower risks of diabetes, high blood pressure, and signs of metabolic syndrome, according to an observational study of nearly 150,000 people across the globe.
Social media ads, posted by UK-based Revival Drinks, has incurred the wrath of the Advertising Standards Authority (ASA), which deems the posts in breach of the rules of use for authorised health claims.
Plant cell culture is an inviting technology to produce bioactives from certain botanicals. The approach is a difficult one to master, however, which is a primary reason why it is still somewhat rare in the market.
The European Commission (EC) makes available a working document that describes the objectives of the nutrition and health claim regulations made on plants and their preparations for food use as ‘not fully attained’.
UK-based microbiome firm Eagle Genomics is to enter into a pact with Cargill as part of a multi-year deal looking to harness artificial intelligence (AI) to the agricultural commodity giant’s microbiome and life sciences R&D.